Adverse Outcome Pathway 298: Increase in Reactive Oxygen Species Leading to Human Treatment-Resistant Gastric Cancer

Shihori Tanabe1, Sabina Quader2, Ryuichi Ono3

  • 1Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan.

Cancers
|January 28, 2026
PubMed

Insights

Increased reactive oxygen species (ROS) drive treatment resistance in human gastric cancer by activating Wnt/beta-catenin signaling and epithelial-mesenchymal transition (EMT). This pathway highlights a key mechanism for gastric cancer therapy resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Toxicology

Background:

  • Gastric cancer exhibits resistance to treatments.
  • Adverse Outcome Pathway (AOP) 298 links increased reactive oxygen species (ROS) to treatment-resistant gastric cancer.
  • ROS plays multifaceted roles in cancer, including progression and apoptosis induction.

Purpose of the Study:

  • To elucidate the role of sustained chronic ROS levels in inducing therapy resistance in human gastric cancer.
  • To detail the sequence of events in AOP 298, from ROS increase to treatment resistance.

Main Methods:

  • The study outlines Adverse Outcome Pathway (AOP) 298, detailing key events and relationships.
  • Focuses on the molecular initiating event (MIE) of increased ROS and subsequent key events (KEs).
  • Examines the pathway involving porcupine-induced Wnt secretion, beta-catenin activation, and epithelial-mesenchymal transition (EMT).

Main Results:

  • AOP 298 describes a causal chain: increased ROS → Wnt signaling activation → beta-catenin activation → EMT → treatment-resistant gastric cancer.
  • Sustained chronic ROS levels are identified as a driver of therapy resistance in gastric cancer.
  • EMT, mediated by Wnt/beta-catenin signaling, confers cancer stem cell-like characteristics.

Conclusions:

  • The Wnt/beta-catenin signaling pathway and subsequent EMT are critical mediators of ROS-induced gastric cancer treatment resistance.
  • Understanding AOP 298 provides insights into mechanisms of therapeutic failure in gastric cancer.
  • Targeting ROS or downstream pathways like Wnt/beta-catenin/EMT may offer strategies to overcome treatment resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Formation of Species01:31

Formation of Species

Speciation describes the formation of one or more new species from one or sometimes multiple original species. The resulting species are discrete from the parent species, and barriers to reproduction will typically exist. There are two primary mechanisms, speciation with and without geographic isolation—allopatric and sympatric speciation, respectively.
45.0K
What is a Species?01:17

What is a Species?

Overview
49.7K
Keystone Species01:39

Keystone Species

Measures of species biodiversity, such as richness (i.e., the number of species present) and evenness (i.e., their relative abundance), describe an ecological community’s structure. Many factors affect community structure, including abiotic factors (e.g., sunlight and nutrients), disturbances (e.g., fire or flood), species interactions (e.g., predation or competition), and chance events (e.g., foreign species invasion). Certain species—such as keystone species—also play a...
24.7K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612